IL6 and lymphoma: Those studies showed that, when compared to HIV subjects that did not progress to lymphoma, high serum levels of IL6, IL10 and IgE were observed specifically among the ones that developed cancer until three years after enrolment (158, 159), reassuring the relevance of this pathway for HIV-associated lymphomas.